{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T17:30:24Z","timestamp":1787160624925,"version":"build-2736575974"},"reference-count":68,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2020,5,6]],"date-time":"2020-05-06T00:00:00Z","timestamp":1588723200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,5,6]],"date-time":"2020-05-06T00:00:00Z","timestamp":1588723200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"name":"Research Vice-Chancellor of Tabriz University of Medical Sciences","award":["3849"],"award-info":[{"award-number":["3849"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Microbiol"],"published-print":{"date-parts":[[2020,9]]},"DOI":"10.1007\/s00284-020-02008-0","type":"journal-article","created":{"date-parts":[[2020,5,6]],"date-time":"2020-05-06T04:06:00Z","timestamp":1588737960000},"page":"2356-2364","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Piperacillin Encapsulation in Nanoliposomes Using Modified Freeze-Drying of a Monophase Solution Method: Preparation, Characterization and In Vitro Antibacterial Activity"],"prefix":"10.1007","volume":"77","author":[{"given":"Pouria","family":"Savadi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Telli","family":"Taghavi-Fard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Morteza","family":"Milani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nastaran","family":"Hashemzadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vahid","family":"Panahi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nigel A. J.","family":"McMillan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Somayeh","family":"Hallaj-Nezhadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,5,6]]},"reference":[{"issue":"4","key":"2008_CR1","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.jiph.2016.08.007","volume":"10","author":"M Frieri","year":"2017","unstructured":"Frieri M, Kumar K, Boutin A (2017) Antibiotic resistance. J Infect Public Health 10(4):369\u2013378","journal-title":"J Infect Public Health"},{"key":"2008_CR2","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.bcp.2016.10.005","volume":"133","author":"\u00c7 Y\u0131lmaz","year":"2017","unstructured":"Y\u0131lmaz \u00c7, \u00d6zcengiz G (2017) Antibiotics: pharmacokinetics, toxicity, resistance and multidrug efflux pumps. Biochem Pharmacol 133:43\u201362","journal-title":"Biochem Pharmacol"},{"issue":"1","key":"2008_CR3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1086\/595011","volume":"48","author":"HW Boucher","year":"2009","unstructured":"Boucher HW, Talbot GH, Bradley JS, Edwards JE, Gilbert D, Rice LB, Scheld M, Spellberg B, Bartlett J (2009) Bad bugs, no drugs: no ESKAPE! An update from the infectious diseases society of America. Clin Infect Dis 48(1):1\u201312","journal-title":"Clin Infect Dis"},{"issue":"Suppl 41","key":"2008_CR4","first-page":"22","volume":"95","author":"P Lambert","year":"2002","unstructured":"Lambert P (2002) Mechanisms of antibiotic resistance in Pseudomonas aeruginosa. J R Soc Med 95(Suppl 41):22","journal-title":"J R Soc Med"},{"key":"2008_CR5","doi-asserted-by":"crossref","first-page":"100640","DOI":"10.1016\/j.drup.2019.07.002","volume":"44","author":"J Botelho","year":"2019","unstructured":"Botelho J, Grosso F, Peixe L (2019) Antibiotic resistance in Pseudomonas aeruginosa: mechanisms, epidemiology and evolution. Drug Resist 44:100640","journal-title":"Drug Resist"},{"issue":"6","key":"2008_CR6","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/j.ijantimicag.2014.02.009","volume":"43","author":"N Abed","year":"2014","unstructured":"Abed N, Couvreur P (2014) Nanocarriers for antibiotics: a promising solution to treat intracellular bacterial infections. Int J Antimicrob Agents 43(6):485\u2013496","journal-title":"Int J Antimicrob Agents"},{"issue":"8","key":"2008_CR7","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/j.tim.2018.01.005","volume":"26","author":"P Dur\u00e3o","year":"2018","unstructured":"Dur\u00e3o P, Balbont\u00edn R, Gordo I (2018) Evolutionary mechanisms shaping the maintenance of antibiotic resistance. Trends Microbiol 26(8):677\u2013691","journal-title":"Trends Microbiol"},{"issue":"48","key":"2008_CR8","doi-asserted-by":"crossref","first-page":"6569","DOI":"10.1039\/c3tb21238f","volume":"1","author":"W Gao","year":"2013","unstructured":"Gao W, Hu C-MJ, Fang RH, Zhang L (2013) Liposome-like nanostructures for drug delivery. J Mater Chem B 1(48):6569\u20136585","journal-title":"J Mater Chem B"},{"key":"2008_CR9","doi-asserted-by":"crossref","first-page":"422","DOI":"10.3389\/fmicb.2018.00422","volume":"9","author":"A Baranwal","year":"2018","unstructured":"Baranwal A, Srivastava A, Kumar P, Bajpai VK, Maurya PK, Chandra P (2018) Prospects of nanostructure materials and their composites as antimicrobial agents. Front Microbiol 9:422","journal-title":"Front Microbiol"},{"issue":"2","key":"2008_CR10","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.jconrel.2011.07.002","volume":"156","author":"AJ Huh","year":"2011","unstructured":"Huh AJ, Kwon YJ (2011) \u201cNanoantibiotics\u201d: a new paradigm for treating infectious diseases using nanomaterials in the antibiotics resistant era. J Control Release 156(2):128\u2013145","journal-title":"J Control Release"},{"issue":"2","key":"2008_CR11","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1039\/C7CS00748E","volume":"48","author":"A Gupta","year":"2019","unstructured":"Gupta A, Mumtaz S, Li C-H, Hussain I, Rotello VM (2019) Combatting antibiotic-resistant bacteria using nanomaterials. Chem Soc Rev 48(2):415\u2013427","journal-title":"Chem Soc Rev"},{"key":"2008_CR12","doi-asserted-by":"crossref","unstructured":"de Souza ME, Verdi CM, de Andrade EN, Santos RC (2019) Antiviral and antimicrobial (antibacterial) potentiality of nano drugs. In: Applications of targeted nano drugs and delivery systems. Elsevier, Amsterdam, pp 327\u2013342","DOI":"10.1016\/B978-0-12-814029-1.00012-0"},{"key":"2008_CR13","doi-asserted-by":"crossref","first-page":"1A","DOI":"10.1099\/acmi.ac2019.po0507","volume":"1","author":"R Catania","year":"2019","unstructured":"Catania R, Maguire O, Moore C, Falcone FH, Chan W, Mantovani G, Stolnik S, Huett A (2019) Functionalised liposomal formulations for delivery of antibiotic agents. Access Microbiol 1:1A","journal-title":"Access Microbiol"},{"key":"2008_CR14","doi-asserted-by":"crossref","first-page":"286","DOI":"10.3389\/fphar.2015.00286","volume":"6","author":"L Sercombe","year":"2015","unstructured":"Sercombe L, Veerati T, Moheimani F, Wu SY, Sood AK, Hua S (2015) Advances and challenges of liposome assisted drug delivery. Front Pharmacol 6:286","journal-title":"Front Pharmacol"},{"issue":"19","key":"2008_CR15","doi-asserted-by":"crossref","first-page":"10938","DOI":"10.1021\/acs.chemrev.5b00046","volume":"115","author":"BS Pattni","year":"2015","unstructured":"Pattni BS, Chupin VV, Torchilin VP (2015) New developments in liposomal drug delivery. Chem Rev 115(19):10938\u201310966","journal-title":"Chem Rev"},{"issue":"9","key":"2008_CR16","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1038\/nbt.3330","volume":"33","author":"E Blanco","year":"2015","unstructured":"Blanco E, Shen H, Ferrari M (2015) Principles of nanoparticle design for overcoming biological barriers to drug delivery. Nat Biotechnol 33(9):941","journal-title":"Nat Biotechnol"},{"issue":"1","key":"2008_CR17","doi-asserted-by":"crossref","first-page":"3","DOI":"10.15171\/apb.2017.002","volume":"7","author":"M Alavi","year":"2017","unstructured":"Alavi M, Karimi N, Safaei M (2017) Application of various types of liposomes in drug delivery systems. Adv Pharm Bull 7(1):3","journal-title":"Adv Pharm Bull"},{"issue":"2","key":"2008_CR18","first-page":"14","volume":"3","author":"J Dua","year":"2012","unstructured":"Dua J, Rana A, Bhandari A (2012) Liposome: methods of preparation and applications. Int J Pharm Stud Res 3(2):14\u201320","journal-title":"Int J Pharm Stud Res"},{"issue":"3","key":"2008_CR19","doi-asserted-by":"crossref","first-page":"297","DOI":"10.2217\/17435889.1.3.297","volume":"1","author":"ML Immordino","year":"2006","unstructured":"Immordino ML, Dosio F, Cattel L (2006) Stealth liposomes: review of the basic science, rationale, and clinical applications, existing and potential. Int J Nanomed 1(3):297","journal-title":"Int J Nanomed"},{"issue":"1","key":"2008_CR20","doi-asserted-by":"crossref","first-page":"2","DOI":"10.4103\/2230-973X.96920","volume":"2","author":"G Tiwari","year":"2012","unstructured":"Tiwari G, Tiwari R, Sriwastawa B, Bhati L, Pandey S, Pandey P, Bannerjee SK (2012) Drug delivery systems: an updated review. Int J Pharm Investig 2(1):2","journal-title":"Int J Pharm Investig"},{"issue":"23","key":"2008_CR21","doi-asserted-by":"crossref","first-page":"8572","DOI":"10.1039\/C8CS00162F","volume":"47","author":"E Rideau","year":"2018","unstructured":"Rideau E, Dimova R, Schwille P, Wurm FR, Landfester K (2018) Liposomes and polymersomes: a comparative review towards cell mimicking. Chem Soc Rev 47(23):8572\u20138610","journal-title":"Chem Soc Rev"},{"issue":"5","key":"2008_CR22","doi-asserted-by":"crossref","first-page":"581","DOI":"10.3109\/10717544.2013.863409","volume":"22","author":"S Hallaj-Nezhadi","year":"2015","unstructured":"Hallaj-Nezhadi S, Hassan M (2015) Nanoliposome-based antibacterial drug delivery. Drug Deliv 22(5):581\u2013589","journal-title":"Drug Deliv"},{"issue":"1\u20132","key":"2008_CR23","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.ijpharm.2009.11.033","volume":"387","author":"Z Drulis-Kawa","year":"2010","unstructured":"Drulis-Kawa Z, Dorotkiewicz-Jach A (2010) Liposomes as delivery systems for antibiotics. Int J Pharm 387(1\u20132):187\u2013198","journal-title":"Int J Pharm"},{"issue":"1","key":"2008_CR24","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1021\/nn900002m","volume":"3","author":"OC Farokhzad","year":"2009","unstructured":"Farokhzad OC, Langer R (2009) Impact of nanotechnology on drug delivery. ACS Nano 3(1):16\u201320","journal-title":"ACS Nano"},{"issue":"2","key":"2008_CR25","doi-asserted-by":"crossref","first-page":"12","DOI":"10.3390\/pharmaceutics9020012","volume":"9","author":"U Bulbake","year":"2017","unstructured":"Bulbake U, Doppalapudi S, Kommineni N, Khan W (2017) Liposomal formulations in clinical use: an updated review. Pharmaceutics 9(2):12","journal-title":"Pharmaceutics"},{"issue":"5","key":"2008_CR26","doi-asserted-by":"crossref","first-page":"805","DOI":"10.2165\/00003495-199957050-00017","volume":"57","author":"CM Perry","year":"1999","unstructured":"Perry CM, Markham A (1999) Piperacillin\/tazobactam. Drugs 57(5):805\u2013843","journal-title":"Drugs"},{"key":"2008_CR27","volume-title":"Martindale: the complete drug reference","author":"SC Sweetman","year":"2002","unstructured":"Sweetman SC (2002) Martindale: the complete drug reference. Pharmaceutical Press, London"},{"issue":"1","key":"2008_CR28","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1128\/AAC.27.1.137","volume":"27","author":"M Nacucchio","year":"1985","unstructured":"Nacucchio M, Bellora M, Sordelli D, D'aquino M (1985) Enhanced liposome-mediated activity of piperacillin against staphylococci. Antimicrob Agents Chemother 27(1):137\u2013139","journal-title":"Antimicrob Agents Chemother"},{"issue":"1","key":"2008_CR29","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.nano.2017.09.007","volume":"14","author":"S Liu","year":"2018","unstructured":"Liu S, Fukushima K, Venkataraman S, Hedrick JL, Yang YY (2018) Supramolecular nanofibers self-assembled from cationic small molecules derived from repurposed poly (ethylene teraphthalate) for antibiotic delivery. Nanomedicine 14(1):165\u2013172","journal-title":"Nanomedicine"},{"issue":"6","key":"2008_CR30","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1002\/jps.20055","volume":"93","author":"C Li","year":"2004","unstructured":"Li C, Deng Y (2004) A novel method for the preparation of liposomes: freeze drying of monophase solutions. J Pharm Sci 93(6):1403\u20131414","journal-title":"J Pharm Sci"},{"key":"2008_CR31","doi-asserted-by":"crossref","unstructured":"Qaiyumi S (2007) Antimicrobial Susceptibility Testing Protocols. In: Richard Schwalbe LS-M, and Avery C. Goodwin. (ed). CRC Press, pp 75\u201381","DOI":"10.1201\/9781420014495.ch4"},{"key":"2008_CR32","volume-title":"Performance Standards for Antimicrobial Susceptibility Testing Twenty-Fourth Informational Supplement; CLSI document M100\u2013S24 Clinical and Laboratory Standards Institute","author":"CLSI","year":"2014","unstructured":"CLSI (2014) Performance Standards for Antimicrobial Susceptibility Testing Twenty-Fourth Informational Supplement; CLSI document M100\u2013S24 Clinical and Laboratory Standards Institute. Wayne, PA, USA"},{"issue":"12","key":"2008_CR33","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1016\/S1473-3099(13)70318-9","volume":"13","author":"R Laxminarayan","year":"2013","unstructured":"Laxminarayan R, Duse A, Wattal C, Zaidi AK, Wertheim HF, Sumpradit N, Vlieghe E, Hara GL, Gould IM, Goossens H (2013) Antibiotic resistance: the need for global solutions. Lancet Infect Dis 13(12):1057\u20131098","journal-title":"Lancet Infect Dis"},{"key":"2008_CR34","first-page":"257","volume":"5","author":"SA Testero","year":"2003","unstructured":"Testero SA, Fisher JF, Mobashery S (2003) \u03b2-Lactam antibiotics. Burger Med Chem Drug Discov 5:257\u2013402","journal-title":"Burger Med Chem Drug Discov"},{"issue":"12","key":"2008_CR35","doi-asserted-by":"crossref","first-page":"1970","DOI":"10.1007\/s00134-006-0355-7","volume":"32","author":"A Combes","year":"2006","unstructured":"Combes A, Luyt C-E, Fagon J-Y, Wolff M, Trouillet J-L, Chastre J (2006) Impact of piperacillin resistance on the outcome of Pseudomonas ventilator-associated pneumonia. Intensive Care Med 32(12):1970\u20131978","journal-title":"Intensive Care Med"},{"issue":"8","key":"2008_CR36","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1086\/339488","volume":"34","author":"J Trouillet","year":"2002","unstructured":"Trouillet J, Vuagnat A, Aa C, Kassis N, Chastre J, Gibert C (2002) Pseudomonas aeruginosa ventilator-associated pneumonia: comparison of episodes due to piperacillin-resistant versus piperacillin-susceptible organisms. Clin Infect Dis 34(8):1047\u20131054","journal-title":"Clin Infect Dis"},{"issue":"6964","key":"2008_CR37","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1038\/nature02122","volume":"426","author":"T-F Mah","year":"2003","unstructured":"Mah T-F, Pitts B, Pellock B, Walker GC, Stewart PS, O'toole GA (2003) A genetic basis for Pseudomonas aeruginosa biofilm antibiotic resistance. Nature 426(6964):306","journal-title":"Nature"},{"key":"2008_CR38","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.drup.2015.08.002","volume":"21","author":"A Oliver","year":"2015","unstructured":"Oliver A, Mulet X, L\u00f3pez-Causap\u00e9 C, Juan C (2015) The increasing threat of Pseudomonas aeruginosa high-risk clones. Drug Resist Updates 21:41\u201359","journal-title":"Drug Resist Updates"},{"issue":"6799","key":"2008_CR39","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1038\/35023079","volume":"406","author":"CK Stover","year":"2000","unstructured":"Stover CK, Pham XQ, Erwin A, Mizoguchi S, Warrener P, Hickey M, Brinkman F, Hufnagle W, Kowalik D, Lagrou M (2000) Complete genome sequence of Pseudomonas aeruginosa PAO1, an opportunistic pathogen. Nature 406(6799):959","journal-title":"Nature"},{"issue":"5","key":"2008_CR40","doi-asserted-by":"crossref","first-page":"449","DOI":"10.2174\/1389450043345407","volume":"5","author":"RM Mainardes","year":"2004","unstructured":"Mainardes RM, Silva LP (2004) Drug delivery systems: past, present, and future. Curr Drug Targets 5(5):449\u2013455","journal-title":"Curr Drug Targets"},{"issue":"3","key":"2008_CR41","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1021\/acsabm.8b00821","volume":"2","author":"C Zhang","year":"2019","unstructured":"Zhang C, Zhao W, Bian C, Hou X, Deng B, McComb DW, Chen X, Dong Y (2019) Antibiotic-derived lipid nanoparticles to treat intracellular Staphylococcus aureus. ACS Appl Biomater 2(3):1270\u20131277","journal-title":"ACS Appl Biomater"},{"issue":"1","key":"2008_CR42","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/ph12010001","volume":"12","author":"L Ar\u00e9valo","year":"2019","unstructured":"Ar\u00e9valo L, Yarce C, O\u00f1ate-Garz\u00f3n J, Salamanca C (2019) Decrease of antimicrobial resistance through polyelectrolyte-coated nanoliposomes loaded with \u03b2-lactam drug. Pharmaceuticals 12(1):1","journal-title":"Pharmaceuticals"},{"key":"2008_CR43","doi-asserted-by":"crossref","unstructured":"Teixeira M, Sanchez-Lopez E, Espina M, Calpena A, Silva AM, Veiga F, Garcia M, Souto EB (2018) Advances in antibiotic nanotherapy: overcoming antimicrobial resistance. In: Emerging nanotechnologies in immunology. Elsevier, Amsterdam, pp 233\u2013259","DOI":"10.1016\/B978-0-323-40016-9.00009-9"},{"issue":"2","key":"2008_CR44","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1093\/jac\/dkh518","volume":"55","author":"C Mugabe","year":"2005","unstructured":"Mugabe C, Azghani AO, Omri A (2005) Liposome-mediated gentamicin delivery: development and activity against resistant strains of Pseudomonas aeruginosa isolated from cystic fibrosis patients. J Antimicrob Chemother 55(2):269\u2013271","journal-title":"J Antimicrob Chemother"},{"key":"2008_CR45","first-page":"1","volume":"3","author":"M Budai","year":"2009","unstructured":"Budai M, Chapela P, Budai L, Wales ME, Petrikovics I, Zimmer A, Gr\u00f3f P, Klebovich I, Szilasi M (2009) Liposomal oxytetracycline and doxycycline: studies on enhancement of encapsulation efficiency. Drug Discov Ther 3:1","journal-title":"Drug Discov Ther"},{"issue":"8","key":"2008_CR46","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1124\/dmd.115.063602","volume":"43","author":"RK Franklin","year":"2015","unstructured":"Franklin RK, Marcus SA, Talaat AM, KuKanich BK, Sullivan R, Krugner-Higby LA, Heath TD (2015) A novel loading method for doxycycline liposomes for intracellular drug delivery: characterization of in vitro and in vivo release kinetics and efficacy in a J774A. 1. Cell line model of Mycobacterium smegmatis infection. Drug Metab Dispos 43(8):1236\u20131245","journal-title":"Drug Metab Dispos"},{"key":"2008_CR47","unstructured":"Pignatello R, Nicolosi D, Nicolosi VM (2011) Fusogenic liposomes as new carriers to enlarge the spectrum of action of antibiotic drugs against Gram-negative bacteria. In: Science against microbial pathogens: communicating current research and technological advances, pp 52\u201360"},{"issue":"2","key":"2008_CR48","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.ajps.2014.09.004","volume":"10","author":"J Li","year":"2015","unstructured":"Li J, Wang X, Zhang T, Wang C, Huang Z, Luo X, Deng Y (2015) A review on phospholipids and their main applications in drug delivery systems. Asian J Pharm Sci 10(2):81\u201398","journal-title":"Asian J Pharm Sci"},{"issue":"23","key":"2008_CR49","doi-asserted-by":"crossref","first-page":"4283","DOI":"10.1016\/S0142-9612(03)00331-4","volume":"24","author":"B Heurtault","year":"2003","unstructured":"Heurtault B, Saulnier P, Pech B, Proust J-E, Benoit J-P (2003) Physico-chemical stability of colloidal lipid particles. Biomaterials 24(23):4283\u20134300","journal-title":"Biomaterials"},{"issue":"2","key":"2008_CR50","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1021\/la034780b","volume":"20","author":"C Matos","year":"2004","unstructured":"Matos C, de Castro B, Gameiro P, Lima JL, Reis S (2004) Zeta-potential measurements as a tool to quantify the effect of charged drugs on the surface potential of egg phosphatidylcholine liposomes. Langmuir 20(2):369\u2013377","journal-title":"Langmuir"},{"issue":"2","key":"2008_CR51","doi-asserted-by":"crossref","first-page":"69","DOI":"10.3390\/pharmaceutics11020069","volume":"11","author":"ML Moy\u00e1","year":"2019","unstructured":"Moy\u00e1 ML, L\u00f3pez-L\u00f3pez M, Lebr\u00f3n JA, Ostos FJ, P\u00e9rez D, Camacho V, Beck I, Merino-Boh\u00f3rquez V, Camean M, Madinabeitia N (2019) Preparation and characterization of new liposomes. Bactericidal activity of cefepime encapsulated into cationic liposomes. Pharmaceutics 11(2):69","journal-title":"Pharmaceutics"},{"issue":"3","key":"2008_CR52","doi-asserted-by":"crossref","first-page":"183","DOI":"10.3109\/19396368.2014.902521","volume":"60","author":"S Mutalik","year":"2014","unstructured":"Mutalik S, Salian SR, Avadhani K, Menon J, Joshi H, Hegde AR, Kumar P, Kalthur G, Adiga SK (2014) Liposome encapsulated soy lecithin and cholesterol can efficiently replace chicken egg yolk in human semen cryopreservation medium. Syst Biol Reprod Med 60(3):183\u2013188","journal-title":"Syst Biol Reprod Med"},{"issue":"5","key":"2008_CR53","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1080\/10717540601098799","volume":"14","author":"T Yang","year":"2007","unstructured":"Yang T, Cui F-D, Choi M-K, Lin H, Chung S-J, Shim C-K, Kim D-D (2007) Liposome formulation of paclitaxel with enhanced solubility and stability. Drug Deliv 14(5):301\u2013308","journal-title":"Drug Deliv"},{"key":"2008_CR54","doi-asserted-by":"crossref","first-page":"557","DOI":"10.2147\/IJN.S14615","volume":"6","author":"B Ruozi","year":"2011","unstructured":"Ruozi B, Belletti D, Tombesi A, Tosi G, Bondioli L, Forni F, Vandelli MA (2011) AFM, ESEM, TEM, and CLSM in liposomal characterization: a comparative study. Int J Nanomed 6:557","journal-title":"Int J Nanomed"},{"issue":"2","key":"2008_CR55","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1590\/S0104-66322004000200002","volume":"21","author":"E Cabral","year":"2004","unstructured":"Cabral E, Zollner R, Santana M (2004) Preparation and characterization of liposomes entrapping allergenic proteins. Braz J Chem Eng 21(2):137\u2013146","journal-title":"Braz J Chem Eng"},{"issue":"4","key":"2008_CR56","doi-asserted-by":"crossref","first-page":"285","DOI":"10.15171\/PS.2017.42","volume":"23","author":"RW Nugraheni","year":"2017","unstructured":"Nugraheni RW, Setyawan D, Yusuf H (2017) Physical characteristics of liposomal formulation dispersed in HPMC matrix and freeze-dried using maltodextrin and mannitol as lyoprotectant. Pharm Sci 23(4):285\u2013292","journal-title":"Pharm Sci"},{"issue":"2","key":"2008_CR57","first-page":"48","volume":"8","author":"B Akbari","year":"2011","unstructured":"Akbari B, Tavandashti MP, Zandrahimi M (2011) Particle size characterization of nanoparticles: a practical approach. Iran J Mater Sci Eng 8(2):48\u201356","journal-title":"Iran J Mater Sci Eng"},{"issue":"10","key":"2008_CR58","doi-asserted-by":"crossref","first-page":"2333","DOI":"10.1007\/s11095-006-9086-2","volume":"23","author":"S Bates","year":"2006","unstructured":"Bates S, Zografi G, Engers D, Morris K, Crowley K, Newman A (2006) Analysis of amorphous and nanocrystalline solids from their X-ray diffraction patterns. Pharm Res 23(10):2333\u20132349","journal-title":"Pharm Res"},{"issue":"1","key":"2008_CR59","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1186\/s13054-016-1255-z","volume":"20","author":"J Zander","year":"2016","unstructured":"Zander J, D\u00f6bbeler G, Nagel D, Maier B, Scharf C, Huseyn-Zada M, Jung J, Frey L, Vogeser M, Zoller M (2016) Piperacillin concentration in relation to therapeutic range in critically ill patients: a prospective observational study. Crit Care 20(1):79","journal-title":"Crit Care"},{"issue":"Suppl 1","key":"2008_CR60","doi-asserted-by":"crossref","first-page":"A132","DOI":"10.1136\/ejhpharm-2013-000276.036","volume":"20","author":"F Scheer","year":"2013","unstructured":"Scheer F, Kraemer I (2013) PHC-021 pharmacokinetics of piperacillin and ciprofloxacin in critically ill patients undergoing continuous venovenous haemodialysis (CVVHD) or continuous venovenous haemodiafiltration (CVVHDF). Eur J Hosp Pharm Sci Pract 20(Suppl 1):A132\u2013A133","journal-title":"Eur J Hosp Pharm Sci Pract"},{"issue":"2","key":"2008_CR61","doi-asserted-by":"crossref","first-page":"91","DOI":"10.7555\/JBR.31.20160146","volume":"32","author":"Q Wang","year":"2018","unstructured":"Wang Q, Chao Y (2018) Multifunctional quantum dots and liposome complexes in drug delivery. J Biomed Res 32(2):91","journal-title":"J Biomed Res"},{"issue":"30","key":"2008_CR62","doi-asserted-by":"crossref","first-page":"6035","DOI":"10.1016\/j.biomaterials.2009.07.033","volume":"30","author":"D Yang","year":"2009","unstructured":"Yang D, Pornpattananangkul D, Nakatsuji T, Chan M, Carson D, Huang C-M, Zhang L (2009) The antimicrobial activity of liposomal lauric acids against Propionibacterium acnes. Biomaterials 30(30):6035\u20136040","journal-title":"Biomaterials"},{"issue":"1","key":"2008_CR63","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1080\/08982104.2016.1247101","volume":"28","author":"S Holzschuh","year":"2018","unstructured":"Holzschuh S, Kae\u00df K, Bossa GV, Decker C, Fahr A, May S (2018) Investigations of the influence of liposome composition on vesicle stability and drug transfer in human plasma: a transfer study. J Liposome Res 28(1):22\u201334","journal-title":"J Liposome Res"},{"issue":"1\u20132","key":"2008_CR64","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.ijpharm.2004.07.010","volume":"285","author":"A Mohammed","year":"2004","unstructured":"Mohammed A, Weston N, Coombes A, Fitzgerald M, Perrie Y (2004) Liposome formulation of poorly water soluble drugs: optimisation of drug loading and ESEM analysis of stability. Int J Pharm 285(1\u20132):23\u201334","journal-title":"Int J Pharm"},{"issue":"11","key":"2008_CR65","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1517\/17425247.2013.822860","volume":"10","author":"M Alhariri","year":"2013","unstructured":"Alhariri M, Azghani A, Omri A (2013) Liposomal antibiotics for the treatment of infectious diseases. Expert Opin Drug Deliv 10(11):1515\u20131532","journal-title":"Expert Opin Drug Deliv"},{"key":"2008_CR66","doi-asserted-by":"crossref","unstructured":"Salem II, Flasher DL, D\u00fczg\u00fcne\u015f N (2005) Liposome-encapsulated antibiotics. In: Methods in enzymology, vol 391. Elsevier, Amsterdam, pp 261\u2013291","DOI":"10.1016\/S0076-6879(05)91015-X"},{"issue":"3","key":"2008_CR67","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/S0924-8579(99)00121-1","volume":"13","author":"H Pinto-Alphandary","year":"2000","unstructured":"Pinto-Alphandary H, Andremont A, Couvreur P (2000) Targeted delivery of antibiotics using liposomes and nanoparticles: research and applications. Int J Antimicrob Agents 13(3):155\u2013168","journal-title":"Int J Antimicrob Agents"},{"key":"2008_CR68","doi-asserted-by":"crossref","first-page":"1794","DOI":"10.1021\/acsinfecdis.9b00232","volume":"10","author":"GA Gonzalez","year":"2019","unstructured":"Gonzalez GA, Xu C, Hosseinidoust Z (2019) Preserving efficacy of glycopeptide antibiotics during nano-encapsulation in liposomes. ACS Infect Dis 10:1794\u20131801","journal-title":"ACS Infect Dis"}],"container-title":["Current Microbiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00284-020-02008-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00284-020-02008-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00284-020-02008-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,30]],"date-time":"2023-09-30T14:57:54Z","timestamp":1696085874000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00284-020-02008-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5,6]]},"references-count":68,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2020,9]]}},"alternative-id":["2008"],"URL":"https:\/\/doi.org\/10.1007\/s00284-020-02008-0","relation":{},"ISSN":["0343-8651","1432-0991"],"issn-type":[{"value":"0343-8651","type":"print"},{"value":"1432-0991","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,5,6]]},"assertion":[{"value":"18 December 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 April 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 May 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors report no conflicts of interest. The authors alone are responsible for the content and writing of this article.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interests"}}]}}